Astrana Health, Inc. reported nine-month revenue of $2,961.2 million, up 33%, and attributable net income of $47.1 million, up $30.6 million. The full impact of the cybersecurity incident remains unquantified.
ASTH · Astrana Health, Inc. · Documents
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
Astrana delivered record third-quarter revenue of $1.02 billion and adjusted EBITDA of $77.2 million, up 7% and 13%, respectively. It maintained full-year revenue guidance of $3.9 billion to $4 billion and adjusted EBITDA guidance of $261 million to $274 million.
Astrana Health reported third-quarter revenue of $1,023.6 million, up 7% year-over-year, net income of $20.3 million and adjusted EBITDA of $77.2 million, up 13%.
Astrana Health updated its corporate presentation on September 23, 2026, raising FY2026 Adjusted EBITDA guidance to $255 – $280M and reaffirming revenue guidance of $3,800 – $4,100M and free cash flow guidance of $105 – $132.5M.
Astrana Health, Inc. deemed a social-engineering incident material on September 22, 2026; it believes private or confidential information may have been accessed, but cannot estimate impact and does not expect a material effect on financial condition or results of operations.